Joseph S. Zakrzewski

Insider Reports History

Entity
Individual
Location
509 Waterview Place, New Hope, PA
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph S. Zakrzewski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 406K $568K $1.40 Nov 27, 2024 Indirect
Cyteir Therapeutics, Inc. Director Common Stock 227K $384K $1.69 Feb 6, 2024 Direct
Cyteir Therapeutics, Inc. Director Common Stock 149K $252K $1.69 Feb 6, 2024 Indirect
AMARIN CORP PLC\UK Director Ordinary Shares 197K $214K $1.09 Dec 15, 2021 Direct
AN2 Therapeutics, Inc. Director Common Stock 125K $175K $1.40 Nov 27, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 60.7K $23.2K $0.38 Feb 25, 2022 Direct
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 64.5K Jun 19, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 25K Feb 25, 2022 Direct
ACCELERON PHARMA INC Director Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 Nov 19, 2021 Direct
Cyteir Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Feb 6, 2024 Direct

Insider Reports Filed by Joseph S. Zakrzewski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Nov 27, 2024 1 $2.8K 4 Nov 27, 2024 Director
ANTX AN2 Therapeutics, Inc. Nov 18, 2024 2 $25K 4 Nov 20, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
CYT Cyteir Therapeutics, Inc. Feb 6, 2024 2 $23.9K 4 Feb 8, 2024 Director
ANTX AN2 Therapeutics, Inc. Jan 18, 2024 1 -$1.91M 4 Jan 19, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
CYT Cyteir Therapeutics, Inc. Feb 3, 2023 1 $0 4 Feb 7, 2023 Director
CYT Cyteir Therapeutics, Inc. Dec 7, 2022 0 $0 4/A Dec 8, 2022 Director
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
CYT Cyteir Therapeutics, Inc. May 12, 2022 1 $1.2K 4 May 16, 2022 Director
CYT Cyteir Therapeutics, Inc. May 10, 2022 2 $95.1K 4 May 12, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 2 $0 4 Mar 31, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 2 $0 4 Mar 1, 2022 Director
CYT Cyteir Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 Director
CYT Cyteir Therapeutics, Inc. Dec 23, 2021 4 $10.9K 4 Dec 28, 2021 Director
CYT Cyteir Therapeutics, Inc. Dec 17, 2021 1 $1.98K 4 Dec 21, 2021 Director
CYT Cyteir Therapeutics, Inc. Dec 15, 2021 2 $39.8K 4 Dec 15, 2021 Director
AMRN AMARIN CORP PLC\UK Dec 14, 2021 2 $39K 4 Dec 16, 2021 Director
XLRN ACCELERON PHARMA INC Nov 19, 2021 8 $0 4 Nov 22, 2021 Director
CYT Cyteir Therapeutics, Inc. Jun 22, 2021 2 $0 4 Jun 24, 2021 Director
CYT Cyteir Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Director
AMRN AMARIN CORP PLC\UK Jun 14, 2021 2 $0 4 Jun 16, 2021 Director